View Future GrowthAnteoTech 과거 순이익 실적과거 기준 점검 0/6AnteoTech 의 수입은 연평균 -2.1%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 0.5%의 비율로 증가했습니다. 매출은 연평균 39.1%의 비율로 감소해 왔습니다.핵심 정보-2.13%순이익 성장률4.37%주당순이익(EPS) 성장률Chemicals 산업 성장률14.45%매출 성장률-39.11%자기자본이익률-294.06%순이익률-1,470.58%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트공시 • Feb 18AnteoTech Limited to Report First Half, 2026 Results on Feb 25, 2026AnteoTech Limited announced that they will report first half, 2026 results on Feb 25, 2026Reported Earnings • Aug 28Full year 2025 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in FY 2024)Full year 2025 results: AU$0.003 loss per share (improved from AU$0.004 loss in FY 2024). Revenue: AU$3.46m (up AU$3.00m from FY 2024). Net loss: AU$6.76m (loss narrowed 24% from FY 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.공시 • Aug 14AnteoTech Limited to Report Fiscal Year 2025 Results on Aug 28, 2025AnteoTech Limited announced that they will report fiscal year 2025 results on Aug 28, 2025공시 • Apr 24AnteoTech Limited to Report Q3, 2025 Results on Apr 30, 2025AnteoTech Limited announced that they will report Q3, 2025 results on Apr 30, 2025공시 • Feb 12AnteoTech Limited to Report First Half, 2025 Results on Feb 26, 2025AnteoTech Limited announced that they will report first half, 2025 results on Feb 26, 2025Reported Earnings • Aug 28Full year 2024 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2023)Full year 2024 results: AU$0.004 loss per share (improved from AU$0.006 loss in FY 2023). Net loss: AU$8.88m (loss narrowed 30% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 49% per year, which means it is performing significantly worse than earnings.모든 업데이트 보기Recent updatesNew Risk • May 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 21% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Revenue is less than US$1m (AU$406k revenue, or US$289k). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (AU$948k net loss in 2 years). Market cap is less than US$100m (AU$50.5m market cap, or US$36.0m).공시 • Feb 18AnteoTech Limited to Report First Half, 2026 Results on Feb 25, 2026AnteoTech Limited announced that they will report first half, 2026 results on Feb 25, 2026공시 • Jan 27AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 3.80835 million.AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 3.80835 million. Security Name: Ordinary Share Security Type: Common Stock Securities Offered: 245,699,993 Price\Range: AUD 0.0155 Discount Per Security: AUD 0.00093 Security Features: Attached Options Transaction Features: Subsequent Direct Listing공시 • Jan 09+ 1 more updateAnteoTech Ltd Announces Resignation of Andrew Cook as Chief Financial OfficerAnteoTech Ltd. announced that Mr. Andrew Cook has tendered his resignation from his role as Chief Financial Officer in order to pursue other business interests.New Risk • Jan 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m (AU$969k revenue, or US$649k). Minor Risks Less than 1 year of cash runway based on current free cash flow (-AU$6.0m). Currently unprofitable and not forecast to become profitable over next 3 years (AU$500k net loss in 3 years). Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (AU$60.0m market cap, or US$40.2m).공시 • Oct 03AnteoTech Limited, Annual General Meeting, Nov 26, 2025AnteoTech Limited, Annual General Meeting, Nov 26, 2025.Reported Earnings • Aug 28Full year 2025 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in FY 2024)Full year 2025 results: AU$0.003 loss per share (improved from AU$0.004 loss in FY 2024). Revenue: AU$3.46m (up AU$3.00m from FY 2024). Net loss: AU$6.76m (loss narrowed 24% from FY 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.공시 • Aug 14AnteoTech Limited to Report Fiscal Year 2025 Results on Aug 28, 2025AnteoTech Limited announced that they will report fiscal year 2025 results on Aug 28, 2025공시 • Apr 24AnteoTech Limited to Report Q3, 2025 Results on Apr 30, 2025AnteoTech Limited announced that they will report Q3, 2025 results on Apr 30, 2025공시 • Apr 15+ 1 more updateAnteoTech Limited Announces Chief Executive Officer ChangesAnteoTech Ltd. announced the appointment of Ms. Merrill Gray as Interim Chief Executive Officer (CEO). Mr. Radford has stepped down as CEO effective 15 April 2025. He will continue to serve the Company as a Strategic Advisor over the coming four weeks working with Ms. Gray to continue to advance the commercialisation of Anteotech's products and technology in both the Clean Energy and Life Sciences markets. Mr. Radford was appointed to the CEO role in October 2022 and has led the Company through an important transition from an R&D focus to initial product sales with global companies and the building of a sales pipeline with multiple potential customers and business partners. The Board would like to sincerely thank Mr. Radford for his significant contributions to the Company over this period. The Board has appointed Ms. Merrill Gray as Interim CEO effective as of 16 April 2025. Ms. Gray is an experienced ASX listed MD/CEO and Senior Executive with over 30 years' experience in mineral processing, energy transitioning. Since 2021 she has focussed on critical minerals and battery materials supply chains including working globally. Throughout her career Ms. Gray has worked closely with emerging technologies and the development of new markets. She understands the challenges and opportunities involved in commercialising technologies in emerging global markets. Ms. Gray holds a Bachelor of Engineering, Bachelor of Science and Master of Business Administration.공시 • Feb 12AnteoTech Limited to Report First Half, 2025 Results on Feb 26, 2025AnteoTech Limited announced that they will report first half, 2025 results on Feb 26, 2025공시 • Nov 20AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 3.5 million.AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 3.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 175,000,000 Price\Range: AUD 0.02 Discount Per Security: AUD 0.0012 Transaction Features: Subsequent Direct Listing공시 • Nov 14AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 4.97954 million.AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 4.97954 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 248,977,000 Price\Range: AUD 0.02 Discount Per Security: AUD 0.0012 Transaction Features: Rights Offering공시 • Oct 02AnteoTech Limited, Annual General Meeting, Nov 26, 2024AnteoTech Limited, Annual General Meeting, Nov 26, 2024.New Risk • Aug 28New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$7.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$7.6m free cash flow). Earnings have declined by 28% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (14% increase in shares outstanding). Revenue is less than US$5m (AU$4.3m revenue, or US$2.9m). Market cap is less than US$100m (AU$51.8m market cap, or US$35.2m).Reported Earnings • Aug 28Full year 2024 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2023)Full year 2024 results: AU$0.004 loss per share (improved from AU$0.006 loss in FY 2023). Net loss: AU$8.88m (loss narrowed 30% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 49% per year, which means it is performing significantly worse than earnings.공시 • Aug 22AnteoTech Limited to Report Fiscal Year 2024 Results on Aug 28, 2024AnteoTech Limited announced that they will report fiscal year 2024 results on Aug 28, 2024공시 • Apr 28AnteoTech Limited, Annual General Meeting, May 28, 2024AnteoTech Limited, Annual General Meeting, May 28, 2024, at 11:30 E. Australia Standard Time. Location: the offices of Sparke Helmore Lawyers, Level 23, 240 Queen Street Brisbane Queensland Australia Agenda: To consider ratification of prior issue of placement shares; to consider ratification of prior issue of SPP shares; to consider approval of issue of new options; to consider approval of issue of placement shares and new options to directors; and to consider other matters.공시 • Apr 10AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 5.4 million.AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 5.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 216,000,000 Price\Range: AUD 0.025 Discount Per Security: AUD 0.0015 Security Features: Attached Options Transaction Features: Subsequent Direct Listing공시 • Apr 09AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million.AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 100,000,000 Price\Range: AUD 0.025 Discount Per Security: AUD 0.0015 Security Features: Attached Options공시 • Feb 23AnteoTech Limited to Report First Half, 2024 Results on Feb 28, 2024AnteoTech Limited announced that they will report first half, 2024 results on Feb 28, 2024New Risk • Nov 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$8.8m free cash flow). Earnings have declined by 36% per year over the past 5 years. Revenue is less than US$1m (AU$366k revenue, or US$242k). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (10% increase in shares outstanding). Market cap is less than US$100m (AU$74.7m market cap, or US$49.4m).공시 • Sep 27AnteoTech Limited, Annual General Meeting, Nov 14, 2023AnteoTech Limited, Annual General Meeting, Nov 14, 2023.Reported Earnings • Aug 30Full year 2023 earnings released: AU$0.006 loss per share (vs AU$0.005 loss in FY 2022)Full year 2023 results: AU$0.006 loss per share (further deteriorated from AU$0.005 loss in FY 2022). Net loss: AU$12.7m (loss widened 18% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.New Risk • Aug 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$10m free cash flow). Earnings have declined by 32% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (9.4% increase in shares outstanding). Revenue is less than US$5m (AU$1.9m revenue, or US$1.3m). Market cap is less than US$100m (AU$60.9m market cap, or US$39.4m).공시 • Aug 22+ 1 more updateAnteotech Limited Announces Appointment of Mr. Andrew Cook as Chief Financial OfficerAnteoTech Ltd. announce the appointment of Mr. Andrew Cook as Chief Financial Officer and Company Secretary effective from 28th August 2023.Andrew's financial expertise with public, listed companies, leading international teams and negotiating contracts with large corporates represents a key hire and strengthens AnteoTech's commercial leadership capabilities at this critical growth phase in the business. Andrew has over 20 years' experience in financial roles with a diverse background across both private and public companies, experience across multiple continents and in a range of industries with a recent focus on energy and renewables. Andrew also has experience in equity and debt fundraising initiatives with public companies. Prior to joining AnteoTech, Andrew was Chief Financial Officer of Entyr Limited, an ASX listed clean conversion technology company that converts end of life tyres into valuable secondary products. Andrew has spent 11 years working in the energy sector, and prior to joining Entyr held a range of roles including Business Transformation Manager of Energy Queensland where he facilitated a comprehensive enterprise transformation program, and as a national Group Manager Commercial for the Generation division of Origin Energy Limited, a $14B ASX listed energy business, where he was integral to the commercial diligence and business integration on the $0.8B acquisition of Eraring Energy. Andrew also spent 5 years at SABMiller Plc, a multinational beverages company, where he rose to become Finance Development Director for Latin America, responsible for coordinating the finance and commercial function across six countries in the region. Andrew is a qualified Chartered Accountant and holds a Bachelor of Commerce. Andrew's remuneration package is in line with industry standards for his level of experience and along with other members of the leadership team he is eligible for the Company's incentive scheme. This appointment follows an extensive executive search and AnteoTech thanks Tom Milicevic who has been cting Chief Financial Officer and Company Secretary. Tom will remain available to facilitate an orderly transition of the finance function and company secretary duties.공시 • Aug 21AnteoTech Limited to Report Fiscal Year 2023 Results on Aug 30, 2023AnteoTech Limited announced that they will report fiscal year 2023 results on Aug 30, 2023공시 • Jun 27AnteoTech Limited Announces Retirement of Christopher Parker from the Board of DirectorsAnteoTech Ltd. announced the retirement of Christopher Parker from the board of directors on 27 June 2023. Mr. Parker was appointed to the company board on 23 April 2019 having previously served as Chief Executive Officer since first joining the company in April 2018. In particular, he held the position of Executive Director from March 2022 to September 2022 during a period of substantial change for the company.Reported Earnings • Feb 22First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)First half 2023 results: AU$0.002 loss per share (in line with 1H 2022). Net loss: AU$3.55m (loss narrowed 7.2% from 1H 2022). Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings.공시 • Feb 15AnteoTech Limited Appoints Tsui Min Lian as Chief Marketing Officer, Effective 15 March 2023AnteoTech Limited announced the appointment of Ms. Tsui Min Lian to the newly created position of Chief Marketing Officer effective 15 March 2023. The appointment of Ms. Lian, initially on a contract basis, is part of the Company's increasing focus on becoming a marketing lead sales-driven business. Ms. Lian is an experienced sales and marketing leader with extensive local and international experience, having worked for Blue Chip companies, including General Electric, ResMed and Toll Group, where she has been responsible for driving growth and profitability within the business units. As a qualified pharmacist, Ms Lian has a proven track record in commercialisation, translating technology and ideas into new products and services, building strategic partnerships and commercial models within multiple industry sectors with a focus upon the delivery of profitable revenue growth. This experience will bring a new focus upon the Life Sciences and Clean Energy Technology businesses as the Company moves to accelerate the commercialisation of its products and services. Ms. Lian holds an MBA from the University of Adelaide, a Graduate Diploma in Marketing, and a BSc (Hons) Pharmacy from the UK.Recent Insider Transactions • Dec 18Non-Executive Director recently sold AU$61k worth of stockOn the 16th of December, Geoffrey Cumming sold around 1m shares on-market at roughly AU$0.061 per share. This transaction amounted to 4.0% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$443k more than they bought in the last 12 months.Board Change • Nov 17High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. 1 highly experienced director. Non-Executive Director Geoff Cumming is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Aug 25Full year 2022 earnings released: AU$0.005 loss per share (vs AU$0.003 loss in FY 2021)Full year 2022 results: AU$0.005 loss per share (down from AU$0.003 loss in FY 2021). Net loss: AU$10.7m (loss widened 72% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has increased by 69% per year, which means it is well ahead of earnings.Recent Insider Transactions • Jun 18Non-Executive Director recently sold AU$106k worth of stockOn the 14th of June, Geoffrey Cumming sold around 2m shares on-market at roughly AU$0.071 per share. In the last 3 months, they made an even bigger sale worth AU$220k. Insiders have been net sellers, collectively disposing of AU$461k more than they bought in the last 12 months.Recent Insider Transactions • May 06Non-Executive Director recently sold AU$220k worth of stockOn the 3rd of May, Geoffrey Cumming sold around 2m shares on-market at roughly AU$0.11 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$382k more than they bought in the last 12 months.Board Change • Apr 27High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. 1 highly experienced director. Non-Executive Director Geoff Cumming is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Recent Insider Transactions • Dec 27Non-Executive Director recently sold AU$108k worth of stockOn the 23rd of December, Geoffrey Cumming sold around 500k shares on-market at roughly AU$0.22 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$162k more than they bought in the last 12 months.Executive Departure • Dec 01Company Secretary Duncan Cornish has left the companyOn the 30th of November, Duncan Cornish's tenure as Company Secretary ended after 2.8 years in the role. As of September 2021, Duncan still personally held 962.15k shares (AU$255k worth at the time). A total of 3 executives have left over the last 12 months. The current median tenure of the management team is 2.79 years.Board Change • Nov 01High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 1 highly experienced director. Non-Executive Director Geoff Cumming is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • Oct 02High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 1 highly experienced director. Non-Executive Director Geoff Cumming is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Recent Insider Transactions • Sep 22Independent Non-Executive Director recently bought AU$59k worth of stockOn the 17th of September, Glenda McLoughlin bought around 250k shares on-market at roughly AU$0.23 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold AU$183k more in shares than they bought in the last 12 months.Board Change • Sep 08Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Chairman Jack Hamilton was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Sep 02Full year 2021 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2020)Full year 2021 results: Net loss: AU$6.22m (loss widened 99% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 129% per year, which means it is well ahead of earnings.Executive Departure • Sep 01Chief Financial Officer Gail Jukes has left the companyOn the 31st of August, Gail Jukes' tenure as Chief Financial Officer ended after less than a year in the role. We don't have any record of a personal shareholding under Gail's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 2.50 years.Recent Insider Transactions • Aug 03Non-Executive Director recently sold AU$112k worth of stockOn the 2nd of August, Geoffrey Cumming sold around 500k shares on-market at roughly AU$0.22 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$241k more than they bought in the last 12 months.Executive Departure • Apr 24Independent Non-Executive Director has left the companyOn the 22nd of April, Matthew Sanderson's tenure as Independent Non-Executive Director ended after 3.5 years in the role. As of December 2020, Matthew personally held 10.28m shares (AU$1.1m worth at the time). Matthew is the only executive to leave the company over the last 12 months.Reported Earnings • Mar 04First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2020)The company reported a solid first half result with improved revenues and control over costs, although losses increased. First half 2021 results: Revenue: AU$1.75m (up 65% from 1H 2020). Net loss: AU$1.47m (loss widened 33% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 141% per year, which means it is tracking significantly ahead of earnings growth.Is New 90 Day High Low • Feb 11New 90-day high: AU$0.22The company is up 147% from its price of AU$0.088 on 13 November 2020. The Australian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Life Sciences industry, which is up 11% over the same period.매출 및 비용 세부 내역AnteoTech가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이CHIA:ADO 매출, 비용 및 순이익 (AUD Millions)날짜매출순이익일반관리비연구개발비31 Dec 250-65330 Sep 251-65430 Jun 251-75431 Mar 25-2-85531 Dec 24-3-95630 Sep 24-1-95630 Jun 240-96631 Mar 241-107531 Dec 231-118430 Sep 231-127530 Jun 230-137631 Mar 231-128631 Dec 222-108530 Sep 221-118630 Jun 221-117631 Mar 221-106631 Dec 211-96630 Sep 211-75530 Jun 211-65431 Mar 211-54331 Dec 202-33330 Sep 202-32330 Jun 201-32231 Mar 201-32231 Dec 191-32230 Sep 191-32230 Jun 190-32231 Mar 191-32231 Dec 181-21230 Sep 181-32230 Jun 181-32231 Dec 170-53230 Sep 171-63230 Jun 172-73231 Dec 164-92330 Sep 163-83330 Jun 162-74431 Mar 167-58431 Dec 151-56330 Sep 151-55430 Jun 150-443양질의 수익: ADO 은(는) 현재 수익성이 없습니다.이익 마진 증가: ADO는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: ADO은 수익성이 없으며 지난 5년 동안 손실이 연평균 2.1% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 ADO의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: ADO은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(4.6%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: ADO는 현재 수익성이 없으므로 자본 수익률이 음수(-294.06%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 15:50종가2026/05/22 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스AnteoTech Limited는 1명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Andrew JohnstonMST Financial Services Pty Limited
공시 • Feb 18AnteoTech Limited to Report First Half, 2026 Results on Feb 25, 2026AnteoTech Limited announced that they will report first half, 2026 results on Feb 25, 2026
Reported Earnings • Aug 28Full year 2025 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in FY 2024)Full year 2025 results: AU$0.003 loss per share (improved from AU$0.004 loss in FY 2024). Revenue: AU$3.46m (up AU$3.00m from FY 2024). Net loss: AU$6.76m (loss narrowed 24% from FY 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.
공시 • Aug 14AnteoTech Limited to Report Fiscal Year 2025 Results on Aug 28, 2025AnteoTech Limited announced that they will report fiscal year 2025 results on Aug 28, 2025
공시 • Apr 24AnteoTech Limited to Report Q3, 2025 Results on Apr 30, 2025AnteoTech Limited announced that they will report Q3, 2025 results on Apr 30, 2025
공시 • Feb 12AnteoTech Limited to Report First Half, 2025 Results on Feb 26, 2025AnteoTech Limited announced that they will report first half, 2025 results on Feb 26, 2025
Reported Earnings • Aug 28Full year 2024 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2023)Full year 2024 results: AU$0.004 loss per share (improved from AU$0.006 loss in FY 2023). Net loss: AU$8.88m (loss narrowed 30% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 49% per year, which means it is performing significantly worse than earnings.
New Risk • May 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 21% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Revenue is less than US$1m (AU$406k revenue, or US$289k). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (AU$948k net loss in 2 years). Market cap is less than US$100m (AU$50.5m market cap, or US$36.0m).
공시 • Feb 18AnteoTech Limited to Report First Half, 2026 Results on Feb 25, 2026AnteoTech Limited announced that they will report first half, 2026 results on Feb 25, 2026
공시 • Jan 27AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 3.80835 million.AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 3.80835 million. Security Name: Ordinary Share Security Type: Common Stock Securities Offered: 245,699,993 Price\Range: AUD 0.0155 Discount Per Security: AUD 0.00093 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
공시 • Jan 09+ 1 more updateAnteoTech Ltd Announces Resignation of Andrew Cook as Chief Financial OfficerAnteoTech Ltd. announced that Mr. Andrew Cook has tendered his resignation from his role as Chief Financial Officer in order to pursue other business interests.
New Risk • Jan 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m (AU$969k revenue, or US$649k). Minor Risks Less than 1 year of cash runway based on current free cash flow (-AU$6.0m). Currently unprofitable and not forecast to become profitable over next 3 years (AU$500k net loss in 3 years). Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (AU$60.0m market cap, or US$40.2m).
공시 • Oct 03AnteoTech Limited, Annual General Meeting, Nov 26, 2025AnteoTech Limited, Annual General Meeting, Nov 26, 2025.
Reported Earnings • Aug 28Full year 2025 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in FY 2024)Full year 2025 results: AU$0.003 loss per share (improved from AU$0.004 loss in FY 2024). Revenue: AU$3.46m (up AU$3.00m from FY 2024). Net loss: AU$6.76m (loss narrowed 24% from FY 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.
공시 • Aug 14AnteoTech Limited to Report Fiscal Year 2025 Results on Aug 28, 2025AnteoTech Limited announced that they will report fiscal year 2025 results on Aug 28, 2025
공시 • Apr 24AnteoTech Limited to Report Q3, 2025 Results on Apr 30, 2025AnteoTech Limited announced that they will report Q3, 2025 results on Apr 30, 2025
공시 • Apr 15+ 1 more updateAnteoTech Limited Announces Chief Executive Officer ChangesAnteoTech Ltd. announced the appointment of Ms. Merrill Gray as Interim Chief Executive Officer (CEO). Mr. Radford has stepped down as CEO effective 15 April 2025. He will continue to serve the Company as a Strategic Advisor over the coming four weeks working with Ms. Gray to continue to advance the commercialisation of Anteotech's products and technology in both the Clean Energy and Life Sciences markets. Mr. Radford was appointed to the CEO role in October 2022 and has led the Company through an important transition from an R&D focus to initial product sales with global companies and the building of a sales pipeline with multiple potential customers and business partners. The Board would like to sincerely thank Mr. Radford for his significant contributions to the Company over this period. The Board has appointed Ms. Merrill Gray as Interim CEO effective as of 16 April 2025. Ms. Gray is an experienced ASX listed MD/CEO and Senior Executive with over 30 years' experience in mineral processing, energy transitioning. Since 2021 she has focussed on critical minerals and battery materials supply chains including working globally. Throughout her career Ms. Gray has worked closely with emerging technologies and the development of new markets. She understands the challenges and opportunities involved in commercialising technologies in emerging global markets. Ms. Gray holds a Bachelor of Engineering, Bachelor of Science and Master of Business Administration.
공시 • Feb 12AnteoTech Limited to Report First Half, 2025 Results on Feb 26, 2025AnteoTech Limited announced that they will report first half, 2025 results on Feb 26, 2025
공시 • Nov 20AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 3.5 million.AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 3.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 175,000,000 Price\Range: AUD 0.02 Discount Per Security: AUD 0.0012 Transaction Features: Subsequent Direct Listing
공시 • Nov 14AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 4.97954 million.AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 4.97954 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 248,977,000 Price\Range: AUD 0.02 Discount Per Security: AUD 0.0012 Transaction Features: Rights Offering
공시 • Oct 02AnteoTech Limited, Annual General Meeting, Nov 26, 2024AnteoTech Limited, Annual General Meeting, Nov 26, 2024.
New Risk • Aug 28New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$7.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$7.6m free cash flow). Earnings have declined by 28% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (14% increase in shares outstanding). Revenue is less than US$5m (AU$4.3m revenue, or US$2.9m). Market cap is less than US$100m (AU$51.8m market cap, or US$35.2m).
Reported Earnings • Aug 28Full year 2024 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2023)Full year 2024 results: AU$0.004 loss per share (improved from AU$0.006 loss in FY 2023). Net loss: AU$8.88m (loss narrowed 30% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 49% per year, which means it is performing significantly worse than earnings.
공시 • Aug 22AnteoTech Limited to Report Fiscal Year 2024 Results on Aug 28, 2024AnteoTech Limited announced that they will report fiscal year 2024 results on Aug 28, 2024
공시 • Apr 28AnteoTech Limited, Annual General Meeting, May 28, 2024AnteoTech Limited, Annual General Meeting, May 28, 2024, at 11:30 E. Australia Standard Time. Location: the offices of Sparke Helmore Lawyers, Level 23, 240 Queen Street Brisbane Queensland Australia Agenda: To consider ratification of prior issue of placement shares; to consider ratification of prior issue of SPP shares; to consider approval of issue of new options; to consider approval of issue of placement shares and new options to directors; and to consider other matters.
공시 • Apr 10AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 5.4 million.AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 5.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 216,000,000 Price\Range: AUD 0.025 Discount Per Security: AUD 0.0015 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
공시 • Apr 09AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million.AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 100,000,000 Price\Range: AUD 0.025 Discount Per Security: AUD 0.0015 Security Features: Attached Options
공시 • Feb 23AnteoTech Limited to Report First Half, 2024 Results on Feb 28, 2024AnteoTech Limited announced that they will report first half, 2024 results on Feb 28, 2024
New Risk • Nov 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$8.8m free cash flow). Earnings have declined by 36% per year over the past 5 years. Revenue is less than US$1m (AU$366k revenue, or US$242k). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (10% increase in shares outstanding). Market cap is less than US$100m (AU$74.7m market cap, or US$49.4m).
공시 • Sep 27AnteoTech Limited, Annual General Meeting, Nov 14, 2023AnteoTech Limited, Annual General Meeting, Nov 14, 2023.
Reported Earnings • Aug 30Full year 2023 earnings released: AU$0.006 loss per share (vs AU$0.005 loss in FY 2022)Full year 2023 results: AU$0.006 loss per share (further deteriorated from AU$0.005 loss in FY 2022). Net loss: AU$12.7m (loss widened 18% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
New Risk • Aug 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$10m free cash flow). Earnings have declined by 32% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (9.4% increase in shares outstanding). Revenue is less than US$5m (AU$1.9m revenue, or US$1.3m). Market cap is less than US$100m (AU$60.9m market cap, or US$39.4m).
공시 • Aug 22+ 1 more updateAnteotech Limited Announces Appointment of Mr. Andrew Cook as Chief Financial OfficerAnteoTech Ltd. announce the appointment of Mr. Andrew Cook as Chief Financial Officer and Company Secretary effective from 28th August 2023.Andrew's financial expertise with public, listed companies, leading international teams and negotiating contracts with large corporates represents a key hire and strengthens AnteoTech's commercial leadership capabilities at this critical growth phase in the business. Andrew has over 20 years' experience in financial roles with a diverse background across both private and public companies, experience across multiple continents and in a range of industries with a recent focus on energy and renewables. Andrew also has experience in equity and debt fundraising initiatives with public companies. Prior to joining AnteoTech, Andrew was Chief Financial Officer of Entyr Limited, an ASX listed clean conversion technology company that converts end of life tyres into valuable secondary products. Andrew has spent 11 years working in the energy sector, and prior to joining Entyr held a range of roles including Business Transformation Manager of Energy Queensland where he facilitated a comprehensive enterprise transformation program, and as a national Group Manager Commercial for the Generation division of Origin Energy Limited, a $14B ASX listed energy business, where he was integral to the commercial diligence and business integration on the $0.8B acquisition of Eraring Energy. Andrew also spent 5 years at SABMiller Plc, a multinational beverages company, where he rose to become Finance Development Director for Latin America, responsible for coordinating the finance and commercial function across six countries in the region. Andrew is a qualified Chartered Accountant and holds a Bachelor of Commerce. Andrew's remuneration package is in line with industry standards for his level of experience and along with other members of the leadership team he is eligible for the Company's incentive scheme. This appointment follows an extensive executive search and AnteoTech thanks Tom Milicevic who has been cting Chief Financial Officer and Company Secretary. Tom will remain available to facilitate an orderly transition of the finance function and company secretary duties.
공시 • Aug 21AnteoTech Limited to Report Fiscal Year 2023 Results on Aug 30, 2023AnteoTech Limited announced that they will report fiscal year 2023 results on Aug 30, 2023
공시 • Jun 27AnteoTech Limited Announces Retirement of Christopher Parker from the Board of DirectorsAnteoTech Ltd. announced the retirement of Christopher Parker from the board of directors on 27 June 2023. Mr. Parker was appointed to the company board on 23 April 2019 having previously served as Chief Executive Officer since first joining the company in April 2018. In particular, he held the position of Executive Director from March 2022 to September 2022 during a period of substantial change for the company.
Reported Earnings • Feb 22First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)First half 2023 results: AU$0.002 loss per share (in line with 1H 2022). Net loss: AU$3.55m (loss narrowed 7.2% from 1H 2022). Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings.
공시 • Feb 15AnteoTech Limited Appoints Tsui Min Lian as Chief Marketing Officer, Effective 15 March 2023AnteoTech Limited announced the appointment of Ms. Tsui Min Lian to the newly created position of Chief Marketing Officer effective 15 March 2023. The appointment of Ms. Lian, initially on a contract basis, is part of the Company's increasing focus on becoming a marketing lead sales-driven business. Ms. Lian is an experienced sales and marketing leader with extensive local and international experience, having worked for Blue Chip companies, including General Electric, ResMed and Toll Group, where she has been responsible for driving growth and profitability within the business units. As a qualified pharmacist, Ms Lian has a proven track record in commercialisation, translating technology and ideas into new products and services, building strategic partnerships and commercial models within multiple industry sectors with a focus upon the delivery of profitable revenue growth. This experience will bring a new focus upon the Life Sciences and Clean Energy Technology businesses as the Company moves to accelerate the commercialisation of its products and services. Ms. Lian holds an MBA from the University of Adelaide, a Graduate Diploma in Marketing, and a BSc (Hons) Pharmacy from the UK.
Recent Insider Transactions • Dec 18Non-Executive Director recently sold AU$61k worth of stockOn the 16th of December, Geoffrey Cumming sold around 1m shares on-market at roughly AU$0.061 per share. This transaction amounted to 4.0% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$443k more than they bought in the last 12 months.
Board Change • Nov 17High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. 1 highly experienced director. Non-Executive Director Geoff Cumming is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Aug 25Full year 2022 earnings released: AU$0.005 loss per share (vs AU$0.003 loss in FY 2021)Full year 2022 results: AU$0.005 loss per share (down from AU$0.003 loss in FY 2021). Net loss: AU$10.7m (loss widened 72% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has increased by 69% per year, which means it is well ahead of earnings.
Recent Insider Transactions • Jun 18Non-Executive Director recently sold AU$106k worth of stockOn the 14th of June, Geoffrey Cumming sold around 2m shares on-market at roughly AU$0.071 per share. In the last 3 months, they made an even bigger sale worth AU$220k. Insiders have been net sellers, collectively disposing of AU$461k more than they bought in the last 12 months.
Recent Insider Transactions • May 06Non-Executive Director recently sold AU$220k worth of stockOn the 3rd of May, Geoffrey Cumming sold around 2m shares on-market at roughly AU$0.11 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$382k more than they bought in the last 12 months.
Board Change • Apr 27High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. 1 highly experienced director. Non-Executive Director Geoff Cumming is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Recent Insider Transactions • Dec 27Non-Executive Director recently sold AU$108k worth of stockOn the 23rd of December, Geoffrey Cumming sold around 500k shares on-market at roughly AU$0.22 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$162k more than they bought in the last 12 months.
Executive Departure • Dec 01Company Secretary Duncan Cornish has left the companyOn the 30th of November, Duncan Cornish's tenure as Company Secretary ended after 2.8 years in the role. As of September 2021, Duncan still personally held 962.15k shares (AU$255k worth at the time). A total of 3 executives have left over the last 12 months. The current median tenure of the management team is 2.79 years.
Board Change • Nov 01High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 1 highly experienced director. Non-Executive Director Geoff Cumming is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • Oct 02High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 1 highly experienced director. Non-Executive Director Geoff Cumming is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Recent Insider Transactions • Sep 22Independent Non-Executive Director recently bought AU$59k worth of stockOn the 17th of September, Glenda McLoughlin bought around 250k shares on-market at roughly AU$0.23 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold AU$183k more in shares than they bought in the last 12 months.
Board Change • Sep 08Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Chairman Jack Hamilton was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Sep 02Full year 2021 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2020)Full year 2021 results: Net loss: AU$6.22m (loss widened 99% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 129% per year, which means it is well ahead of earnings.
Executive Departure • Sep 01Chief Financial Officer Gail Jukes has left the companyOn the 31st of August, Gail Jukes' tenure as Chief Financial Officer ended after less than a year in the role. We don't have any record of a personal shareholding under Gail's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 2.50 years.
Recent Insider Transactions • Aug 03Non-Executive Director recently sold AU$112k worth of stockOn the 2nd of August, Geoffrey Cumming sold around 500k shares on-market at roughly AU$0.22 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$241k more than they bought in the last 12 months.
Executive Departure • Apr 24Independent Non-Executive Director has left the companyOn the 22nd of April, Matthew Sanderson's tenure as Independent Non-Executive Director ended after 3.5 years in the role. As of December 2020, Matthew personally held 10.28m shares (AU$1.1m worth at the time). Matthew is the only executive to leave the company over the last 12 months.
Reported Earnings • Mar 04First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2020)The company reported a solid first half result with improved revenues and control over costs, although losses increased. First half 2021 results: Revenue: AU$1.75m (up 65% from 1H 2020). Net loss: AU$1.47m (loss widened 33% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 141% per year, which means it is tracking significantly ahead of earnings growth.
Is New 90 Day High Low • Feb 11New 90-day high: AU$0.22The company is up 147% from its price of AU$0.088 on 13 November 2020. The Australian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Life Sciences industry, which is up 11% over the same period.